SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cells.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer Letters

• Publication date

  1994-10-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0304-3835(94)90275-5PMID 7954337
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) by purified DT-diaphorase under aerobic and anaerobic conditions.

  1993cited by this paper
• Changes in the oxygenation of head and neck tumors during carbogen breathing.

  1993cited by this paper
• Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade brain tumors.

  1993cited by this paper
• Reversal of drug-resistance by exposure of mcf-7 or mcf-7 cddp human breast-carcinoma cells to sr-4233 or etanidazole under hypoxic conditions.

  1993cited by this paper
• Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.

  1993cited by this paper
• Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone.

  1993cited by this paper
• SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.

  1993cited by this paper
• Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di-N-oxide hypoxic cell cytotoxin tirapazamine (WIN 59075; SR 4233; NSC 130181) in mice.

  1993cited by this paper
• Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cells.

  1992cited by this paper
• Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis.

  1992cited by this paper
• The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver.

  1992cited by this paper
• Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements.

  1991cited by this paper
• The clinical relevance of tumour hypoxia.

  1990cited by this paper
• Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines.

  1990cited by this paper
• Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin.

  1990cited by this paper
• Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.

  1990cited by this paper
• Oxygenation of human tumors.

  1990cited by this paper
• Tumor tissue oxygenation as evaluated by computerized-pO2-histography.

  1990cited by this paper
• Aerobic radiosensitization by SR 4233 in vitro and in vivo.

  1990cited by this paper
• Pre- and post-irradiation radiosensitization by SR 4233.

  1989cited by this paper
• Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts.

  1989cited by this paper
• Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins.

  1989cited by this paper
• Pre- and post-irradiation adiosensitization by SR 4233

  1989cited by this paper
• Optimization of perfluorochemical levels with radiation therapy in mice.

  1989cited by this paper
• In vitro hepatotoxicity of SR 4233 (3-amino-1,2,4-benzotriazine-1,4-dioxide), a hypoxic cytotoxin and potential antitumor agent.

  1989cited by this paper
• Structure-activity relationships for benzotriazine di-N-oxides.

  1989cited by this paper
• A linear model of muscle respiration explains monoexponential phosphocreatine changes.

  1988cited by this paper
• Preclinical studies and clinical correlation of the effect of alkylating dose.

  1988cited by this paper
• Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cytotoxicity.

  1988cited by this paper
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

  1988cited by this paper
• Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233.

  1988cited by this paper
• Therapeutic attack of hypoxic cells of solid tumors: presidential address.

  1988cited by this paper
• Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233).

  1988cited by this paper
• Evaluation of oxygen diffusion distances in human breast cancer xenografts using tumor-specific in vivo data: role of various mechanisms in the development of tumor hypoxia.

  1988cited by this paper
• Mechanisms of mitochondrial photosensitization by the cationic dye, N,N-bis(2-ethyl-1,3-dioxylene)kryptocyanine (EDKC): preferential inactivation of complex I in the electron transport chain.

  1987cited by this paper
• Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide.

  1986cited by this paper
• Perfluorochemical emulsions can increase tumor radiosensitivity.

  1984cited by this paper
• Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

  1981cited by this paper
• The hypoxic tumor cell: a target for selective cancer chemotherapy.

  1980cited by this paper
• Mapping of metabolites in whole animals by 31P NMR using surface coils

  1980cited by this paper
• The mechanism of inhibition on the endogenous respiration of Ehrlich ascites tumor cells by the cyanine dye diS-C3-(5).

  1979cited by this paper
• Oxidative metabolism of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine) by rat liver microsomes.

  1979cited by this paper
• Metabolic activation of procarbazine.

  1978cited by this paper
• Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.

  1976cited by this paper
• Experimental studies at Southern Research Institute with DTIC (NSC-45388).

  1976cited by this paper
• Experimental studies at Southern Research Institute with DTIC (NSC-45388).

  1976cited by this paper
• Mechanism of action and pharmacology studies with DTIC (NSC-45388).

  1976cited by this paper
• Fate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells.

  1974cited by this paper
• Chemotherapeutic, carcinogenic, and cell-regulatory effects of triazenes.

  1974cited by this paper
• Analogs of 3-amino-7-chloro-1,2,4-benzotriazine 1-oxide as antimalarial agents.

  1968cited by this paper
• The breakdown of adenosine triphosphate in the contraction cycle of the frog sartorius muscle

  1967cited by this paper
• [45] Cytochrome oxidase from beef heart mitochondria

  1967cited by this paper
• The effect of 2,4-dinitrofluorobenzene on the activity of striated muscle.

  1965cited by this paper
• Benzotriazines. I. A New Series of Compounds Having Antimalarial Activity

  1954cited by this paper

• Enzyme-Activated Generation of Reactive Oxygen Species from Heterocyclic N-Oxides under Aerobic and Anaerobic Conditions and Its Relevance to Hypoxia-Selective Prodrugs.

  2019cites this paper
• Flexible phosphorescent oxygen microsensor array devices for noninvasive monitoring of cellular oxygen metabolism during cultivation

  2012cites this paper
• Metabolic acidosis in prometryn (triazine herbicide) self-poisoning

  2008cites this paper
• Employing Tumor Hypoxia for Oncolytic Therapy in Breast Cancer

  2005cites this paper
• Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.

  2001cites this paper
• Phase I trial of i.v. administered tirapazamine plus cyclophosphamide

  2001cites this paper
• Real‐time measurements of cellular oxygen consumption, pH, and energy metabolism using nuclear magnetic resonance spectroscopy

  2001cites this paper
• Chemosensitization of glioblastoma cells to bis-dichloroethyl-nitrosourea with tyrphostin AG17.

  1998cites this paper
• Rational enzyme-directed prodrug development : exploiting tumour hypoxia to target the bioactivation of cytotoxic prodrugs

  1998cites this paper
• Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.

  1998cites this paper
• Enzymology of tirapazamine metabolism: a review.

  1998cites this paper
• Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors.

  1997cites this paper
• Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.

  1997cites this paper
• Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity.

  1997cites this paper
• Bioreductive agents: a clinical update.

  1997cites this paper
• Relationship of cellular energy parameters to cytotoxicity for AG-17, lonidamine and cyclocreatine in four human tumor cell lines.

  1996cites this paper
• Design and synthesis of new mitochondrial cytotoxin N-thiadiazolylanilines that inhibit tumor cell growth.

  1996cites this paper
• Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.

  1996cites this paper
• New cytotoxic mechanism of the bioreductive agent Tirapazamine (SR 4233) mediated by forming complex with copper

  1996cites this paper
• Combinations of tnp-470 or sr-4233 with antitumor alkylating-agents in emt-6 spheroids and monolayers.

  1995cites this paper